Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers

By sjmartinez • June 27, 2024

French JD, Haugen BR, Worden FP, Bowles DW, Gianoukakis AG, Konda B, Dadu R, Sherman EJ, McCue S, Foster NR, Nikiforov YE, Farias TDJ, Norman PJ, Wirth LJ. Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clin Cancer Res. 2024 Jun 26. doi: 10.1158/1078-0432.CCR-23-3417. Epub ahead of print. PMID: 38922338.

Tags: Endocrinology, Harbor UCLA, Publications

Plea to radiologists: Please consider Mahvash disease when encountering an enlarged pancreas

Yu R. Plea to radiologists: Please consider Mahvash disease when encountering an enlarged pancreas. World J Radiol. 2024 Aug 28;16(8):371-374. doi: 10.4329/wjr.v16.i8.371. PMID: 39239240; PMCID:[...]

Primary Hyperparathyroidism-“Overtones” May Be Overblown

Yeh MW. Primary Hyperparathyroidism-"Overtones" May Be Overblown. JAMA Surg. 2024 Sep 4. doi: 10.1001/jamasurg.2024.3519. Epub ahead of print. PMID: 39230929.

Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol

MoTrPAC Study Group; Jakicic JM, Kohrt WM, Houmard JA, Miller ME, Radom-Aizik S, Rasmussen BB, Ravussin E, Serra M, Stowe CL, Trappe S, Abouassi H,[...]